Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SOUTH GEORGIA TOXICOLOGY, INC

NPI: 1225413099 · VALDOSTA, GA 31605 · Clinical Medical Laboratory · NPI assigned 07/22/2015

$2.83M
Total Medicaid Paid
183,133
Total Claims
153,642
Beneficiaries
43
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDRAMBEL, ED (OWNER)
NPI Enumeration Date07/22/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 34,132 $186K
2019 44,064 $343K
2020 44,047 $448K
2021 19,372 $462K
2022 12,559 $436K
2023 8,931 $544K
2024 20,028 $414K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 17,020 14,672 $2.09M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 2,237 2,112 $174K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 12,303 9,493 $147K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,087 968 $57K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 2,522 2,165 $41K
80356 5,765 4,881 $25K
83992 5,007 4,187 $14K
80361 5,791 4,895 $14K
80367 5,328 4,479 $13K
80323 5,778 4,887 $12K
80347 4,165 3,412 $12K
80321 3,397 2,858 $12K
80357 5,276 4,441 $12K
80373 4,156 3,540 $11K
80372 4,113 3,503 $11K
80366 4,395 3,757 $11K
80370 4,326 3,697 $11K
80355 4,546 3,840 $11K
80368 3,570 2,994 $11K
80365 5,806 4,912 $10K
80354 5,799 4,900 $10K
80358 5,852 4,912 $10K
80348 5,796 4,898 $10K
80359 5,777 4,888 $10K
80353 5,767 4,884 $9K
80371 4,853 4,047 $8K
80345 4,205 3,413 $8K
80338 3,392 2,684 $7K
80333 3,240 2,661 $7K
80363 3,643 3,228 $7K
80336 3,253 2,677 $7K
80364 1,992 1,553 $6K
80342 2,803 2,268 $6K
80349 5,082 4,283 $6K
80350 5,109 4,283 $5K
80360 2,050 1,603 $5K
80324 3,701 3,177 $5K
80325 2,024 1,580 $5K
80346 1,227 1,141 $2K
80369 65 58 $154.57
80332 732 679 $29.70
82570 73 66 $0.00
81003 110 66 $0.00